RecruitingBehavioural interventionImpact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular HealthThe goal of this clinical trial is to evaluate whether disclosure of a polygenic risk score for coronary artery disease (CAD PRS) influences cardiovascular health and risk factor modification over one year among adults aged 30-75 years in the Mass General Brigham primary care network who are not currently taking LDL cholesterol-lowering medications.